United States · 
What does Venture Investors invest in?
Venture Investors invests most often at Series A and Series B (61% of the rounds on record), in sectors such as App Marketing, Apps and Banking.
Venture Investors highlights
- 01
40 rounds on record
- 02
Mostly Series A and Series B: 61% of its rounds
- 03
Sole investor in 7 rounds, median $4.5M
- 04
3 exits from the portfolio
What they do
Filed 1 private fund offering with the SEC, the most recent in 2012-02From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- From $250K as they say
- Stages
- SeedSeries ASeries BGrowthPre-IPO
- Sectors
- App MarketingAppsBanking
- Based in
- Madison, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first40 appearances
- 2024
1 round
- Aug
- 2019
1 round
- Apr
- 2018
1 round
- Jan
- 2015
6 rounds
- Oct
- Sept
- Aug
- Aug
- Jun
- Mar
- 2014
3 rounds
- Jun
- Apr
- Jan
- 2013
8 rounds
- Nov
- Aug
- Aug
- Jun
- Jun
- Jun
- May
- Apr
- 2012
5 rounds
- Sept
- Aug
- Jul
- Mar
- Jan
- 2011
3 rounds
- Apr
- Mar
- Jan
- 2009
1 round
- Oct
- 2008
3 rounds
- May
- Feb
- Jan
- 2007
4 rounds
- Dec
- Sept
- May
- Apr
- 2006
1 round
- Apr
- 2004
2 rounds
- Dec
- Nov
- 2001
1 round
- May
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration9 named
DADavid ArnsteinManaging Director of the General PartneriFiling they signed
GAGeorge AridaManager of the General PartneriFiling they signed
JRJames R AdoxManaging Director of the General PartneriFiling they signed
JNJeremy NeilsonManaging Director of the Issuer's ManageriFiling they signed
JPJohn Peter NeisManaging Director of the General PartneriFiling they signed
JAJoseph AmaralManaging Director of the General PartneriFiling they signed
PMPaul Martin Karl WeissManaging Director of the General PartneriFiling they signed
RTRichard ThomsOfficer of the Issuer's ManageriFiling they signed
SFScott Frederick ButtonManaging Director of the General PartneriFiling they signed
We also hold 12 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$212Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Venture Investors LLC
- SEC number
- CRD 163693
What they claim to have backed
From their own portfolio page (on their website)
3 of 15 we have independently watched raise
Diagnostics 1 ImprovesDigital 1 UsesEXITED Diagnostics 1ClareviaDevices 1 OffersDiagnostics 1 BiologicalDiagnostics 1 BringsDiagnostics 1 BringsDiagnostics 1 ImprovesDiagnostics 1 TargetingPharma 1 BoostsPharma 1 ImprovesPharma 3 AimsPharma 4 DiscoversPharma 5 Targets
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed3 in all
InviragenBought by Takeda PharmaceuticalUndisclosedMay 2013
CellectarBought by Novelos TherapeuticsUndisclosedApr 2011
ZystorBought by BioMarin Pharmaceutical$115MAug 2010
An exit counts when it came after the firm's first round in the company. From historical deal records.